Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Alessandra Franco

    TitleAssociate Adjunct Professor
    SchoolUniversity of California, San Diego
    DepartmentPediatrics
    Address9500 Gilman Drive #0641
    CA La Jolla 92093
    Phone858-246-0160
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Impact of TNFa blockade on immune function in acute Kawasaki disease
      NIH/NHLBI R01HL103536Apr 15, 2010 - Feb 28, 2015
      Role: Principal Investigator
      GENERATION OF THOMSEN-FREIDENREICH-SPECIFIC T CELLS
      NIH/NCI R29CA078657Jul 1, 1998 - Aug 31, 2004
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Bertin S, Aoki-Nonaka Y, Lee J, de Jong PR, Kim P, Han T, Yu T, To K, Takahashi N, Boland BS, Chang JT, Ho SB, Herdman S, Corr M, Franco A, Sharma S, Dong H, Akopian AN, Raz E. The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1. Gut. 2016 Jun 20. PMID: 27325418.
        View in: PubMed
      2. Tremoulet AH, Jain S, Kim S, Newburger J, Arditi M, Franco A, Best B, Burns JC. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial). Contemp Clin Trials. 2016 May; 48:70-5. PMID: 27080929.
        View in: PubMed
      3. Burns JC, Franco A. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease. Expert Rev Clin Immunol. 2015 Jul; 11(7):819-25. PMID: 26099344.
        View in: PubMed
      4. Franco A. Introduction. Autoimmunity. 2015 May; 48(3):137-8. PMID: 25831239.
        View in: PubMed
      5. Burns JC, Touma R, Song Y, Padilla RL, Tremoulet AH, Sidney J, Sette A, Franco A. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease. Autoimmunity. 2015 May; 48(3):181-8. PMID: 25822882.
        View in: PubMed
      6. Franco A, Touma R, Song Y, Shimizu C, Tremoulet AH, Kanegaye JT, Burns JC. Specificity of regulatory T cells that modulate vascular inflammation. Autoimmunity. 2014 Mar; 47(2):95-104. PMID: 24490882.
        View in: PubMed
      7. Ogata S, Shimizu C, Franco A, Touma R, Kanegaye JT, Choudhury BP, Naidu NN, Kanda Y, Hoang LT, Hibberd ML, Tremoulet AH, Varki A, Burns JC. Treatment response in kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin g. PLoS One. 2013; 8(12):e81448. PMID: 24324693.
        View in: PubMed
      8. Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A, Burns JC. The role of TGF-ß and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol. 2013 Feb; 44(2):189-98. PMID: 22955109.
        View in: PubMed
      9. Tremoulet AH, Pancoast P, Franco A, Bujold M, Shimizu C, Onouchi Y, Tamamoto A, Erdem G, Dodd D, Burns JC. Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2012 Sep; 161(3):506-512.e1. PMID: 22484354.
        View in: PubMed
      10. Franco A, Almanza G, Burns JC, Wheeler M, Zanetti M. Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones. Cell Immunol. 2010; 266(1):1-6. PMID: 20951371.
        View in: PubMed
      11. Franco A, Shimizu C, Tremoulet AH, Burns JC. Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity. 2010 Jun; 43(4):317-24. PMID: 20166878.
        View in: PubMed
      12. Franco A. Glycoconjugates as vaccines for cancer immunotherapy: clinical trials and future directions. Anticancer Agents Med Chem. 2008 Jan; 8(1):86-91. PMID: 18220508.
        View in: PubMed
      13. Franco A, Albani S. Translating the concept of suppressor/regulatory T cells to clinical applications. Int Rev Immunol. 2006 Jan-Apr; 25(1-2):27-47. PMID: 16669133.
        View in: PubMed